Analysis of vaccines

Program

In this meeting we will present and make a critical review of methods and techniques for the analysis of vaccines. We aim to stimulate the interaction between specialists on the characterization of vaccines as well as emphasizing the importance of reliable analyses.

More than 5 billion people worldwide have been vaccinated for covid-19 [1]. It is therefore timely to present a program on the characterization of the different types of vaccines that have been used.

• Experts on different types of vaccines will present on the characterization of different components of those vaccines.
• One of the co-founders of the American company Moderna, will present about the messenger RNA technology and his view on its future direction.
• A lecture on the focus of all vaccinations, namely the production of antibodies.

[1] Tracking Coronavirus Vaccinations Around the World, New York Times,  https://www.nytimes.com/interactive/2021/world/covid-vaccinations-tracker.html, 21Jun2022

Target group

We welcome all professionals active in the analysis and control of vaccines and pharmaceuticals, as well as prescribers, users, and those with a general interest in vaccines.

Time and venue

This meeting will take place on January 19, 2023, at Apotekarsocieteten, Wallingatan 26A in Stockholm.

Confirmed lecturers

Kenneth Chien, Karolinska Institute, Solna, Sweden;
Dan Barouch, Harvard Medical School, Boston,USA;
Margareta Ramström Jonsson, Swedish Medical Products Agency, Sweden;
Lars Geurink, Janssen Janssen Vaccines and Prevention, The Netherlands;
Cari Sänger-de Griend, Kantisto, The Netherlands;
Josefina Nilsson, Vironova, Stockholm, Sweden;
Peter Nilsson, Royal Institute of Technology  (KTH), Stockholm, Sweden

Partnership possibilities

For information about partnership possibilities please click here.

When you fill in your application as an exhibitor / sponsor at the meeting, enter which category you want of gold or silver sponsorship and we will make sure that you get the right sponsorship package.

Organizing Committee

Ahmad Amini, Läkemedelsverket, Uppsala
Cari Sänger, Kantisto, The Netherlands
Douglas Westerlund, Uppsala university
Lisa Bandholtz, Apotekarsocieteten, Stockholm
Sophia Hober, KTH, Stockholm
Margareta Ramström, Läkemedelsverket, Stockholm